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Abstract
Background: The protein encoded by the Us11 gene of herpes simplex viruses is a dsRNA binding protein which
inhibits protein kinase R activity, thereby preventing the interferon-induced shut down of protein synthesis
following viral infection. Us11 protein is not essential for infectivity in vitro and in mice in herpes simplex virus type
1 (HSV1), however this virus has a second, and apparently more important, inhibitor of PKR activity, the g134.5
protein. Recently sequenced simian simplexviruses SA8, HVP2 and B virus do not have an ORF corresponding to
the g134.5 protein, yet they have similar, or greater, infectivity as HSV1 and HSV2.
Methods: We have expressed the US11 proteins of the simplexviruses HSV1, HSV2, HVP2 and B virus and measured
their abilities to bind dsRNA, in order to investigate possible differences that could complement the absence of the
g134.5 protein. We employed a filter binding technique that allows binding of the Us11 protein under condition of
excess dsRNA substrate and therefore a measurement of the true Kd value of Us11-dsRNA binding.
Results and Conclusions: The results show a Kd of binding in the range of 0.89 nM to 1.82 nM, with no
significant difference among the four Us11 proteins.
Introduction
The genus Simplexvirus comprises a number of closely
related herpesviruses with very similar genetic structure
and life cycles. Most simplexviruses, like the human
simplex viruses types 1 and 2 (HSV 1 and HSV 2), B
virus (Cercopithecine herpesvirus 1), SA8 (Cercopithecine
herpesvirus 2) and herpes virus papio type 2 (Cercopithe-
cine herpesvirus 16), infect primates and produce very
similar oro-genital lesions in their natural hosts and
may cause encephalitis or severe infections in mice and
other hosts [1]. For example, B virus causes mostly oro-
genital lesions in macaques, but if transmitted to
humans produces an often fatal ascending encephalo-
myelitis [1,2].
Complete sequencing of the genomes of simian sim-
plexviruses have confirmed the close genetic homology
[3-5]. All the genes are conserved and collinear, except
for the g134.5 gene (RL1) which is present in HSV-1
and HSV-2, but absent from the simian simplexviruses
B virus, SA8 and HVP2.
The g134.5 protein is an important virulence factor in
HSV-1. Null mutants for g134.5 loose their virulence in
mice and they show a severely impaired replication in
cells culture [6,7]. These mutants can be rescued by a
compensatory mutation that puts the US11 ORF under
the control of an immediate early promoter [8-10]. In
fact, both g134.5 and US11 proteins act by inhibiting the
activation of the interferon-dependent protein kinase R
(PKR) response. PKR is activated by binding to dsRNA
and it phosphorylates the ribosomal translation factor
eIF2a, thereby blocking cellular protein synthesis. g134.5
promotes de-phosphorylation of eIF2a [7,11] while
US11 inhibits PKR activation by binding to dsRNA
[11,12]. Since simian simplexviruses lack the g134.5 gene
and yet replicate very well in culture and may show
neurovirulence in mice, it is tempting to speculate that
US11 may take over the entire inhibition of the PKR
system in these viruses.
US11 is a ribosome associated protein which is pro-
duced late in infection and is packaged into the viral
tegument at approximately 1000 copies [13,14]. US11 is
not thought to be necessary for early gene expression or
DNA replication, however it has been found that HSV 1
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cycle to prevent an antiviral state [15-17].
US11 is thought to inhibit PKR via the sequestering of
dsRNA [11]. US11 has also been shown to inhibit PKR
activation by binding to PACT, an RNA-independent
mechanism of activating PKR [18]. In addition, US11
has recently been shown to counteract OAS (2’-5’ oli-
goadenylate synthetase), an interferon inducible gene
also activated by dsRNA, in part by sequestering dsRNA
through its C-terminal domain [19].
US11 binds dsRNA via a unique motif comprised of a
set of R-X-P repeats at the C-terminal end of the gene.
The R-X-P motifs bind to dsRNA with high affinity,
with Kds reported in the range of 12 to 70 nM [12,20].
US11 bind to dsRNA of minimum length of 39 bp and
preferentially binds RNA structures of higher-order and
greater sequence complexity [12,20].
Within the simplexviruses that express US11, the pro-
tein is highly conserved except for the number of R-X-P
at the C-terminal end of the protein. HSV 1 contains 20
to 24 copies of R-X-P repeats, the number of repeats
has been shown to vary among viral strains but is not a
strain specific feature. HSV2 contains 19-20 repeats and
this also is thought to vary slightly among strains.
Within the non-human primate viruses; B virus (strain
E2490) contains 20 R-X-P repeats, SA8 strain B264 con-
tains only 10 while HVP2 (strain X313) has 32 R-X-P
repeats, although there is considerable variation in the
number of repeats among HVP2 strains.
In this work we have expressed in E. coli US11 pro-
teins from the human simplexvirus HSV-1, HSV-2, and
the simian simplexviruses HVP-2 and B-virus and we
investigated if there are differences in dsRNA binding
activities that could indicate different roles of US11 in
the two groups of simplexviruses.
Materials and methods
Cell Culture and Viruses
Vero cells (ATCC number CCL-81) were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 5% calf serum. HSV 1 (strain F), HSV 2
(strain G) were obtained from The American Tissue
Culture Collection (ATCC numbers VR-733 and VR-
734, respectively). Herpes papio 2 (HVP2, strain X313),
originally isolated in Dr. Richard Eberle’s laboratory,
University of Oklahoma, and B virus (strain E2490) were
obtained from the Southwest Foundation for Biomedical
Research, San Antonio, TX, USA. Simian agent 8 (SA8,
strain B264) was donated by Dr. Heinz Feldman,
National Microbiology Laboratory, Winnipeg Manitoba.
Viral genomic DNA was prepared as previously
described [4]. Genomic DNA from B virus was prepared
in the biosafety level 4 facility at the National Microbiol-
ogy Laboratory of the Public Health Agency of Canada.
US11 Recombinant Protein Expression and Purification
The US11 gene was amplified by polymerase chain reac-
tion (PCR) using the following sets of primers: HSV1,
forward 5’GGAATTCCATATGAGCCAGACCCAACC3’
and reverse 5’CCCAAGCTTCTATACAGACCCGC-
GAG3’; HSV2, forward 5’ GGAATTCCATATGGCAT
CCGGGGTT3’ and reverse 5’CCCAAGCTTCTAGG-
CAAGCCCGCG3’; B virus, forward 5’GGAATTCCA-
TATGCTAATGGCGTCAA3’ and reverse 5’CCCAAGC
TTGAAACCTCATCAACCC3’;S A 8 ,f o r w a r d5 ’GGAAT
TCCATATGGCGTCCGCGCCC3’ and reverse 5’CCC
AAGCTTAGGGGGCCGTCCTCACC3’;a n dH V P 2f o r -
ward 5’GGAATTCCATATGGCGTCCGTGGCC3’ and
reverse 5’CCCAAGCTTAGGGGGCCGTCCTCAC3’.
The oligonucleotides were designed using the software
VectorNTI (Invitrogen, CA, USA), on the basis of the
following GenBank sequences: HSV 1 strain 17
(NC_001806), HSV2 strain HG52 (NC_001798), B virus
strain E2490 (NC_004812), SA8 (NC_006560), HVP2
(NC_007653), and contained HindIII and NdeI restric-
tion sites at the 3’ and 5’ ends respectively, for cloning
into the E. coli expression vector pET28a(+) (Novagen,
CA, USA). The US11 clones, containing an amino term-
inal hexahistidine tag, were produced in BL21 (DE3)
competent E. coli cells (Novagen, CA, USA) and
sequenced for confirmation at the DNA Core Facility
(National Microbiology Laboratory, Winnipeg).
For expression of the US11 proteins, E. coli clones
w e r eg r o w ni n1 Lo fL Bm e d i u mt oa nO D 600 of about
0.6 in the presence of 50 μg/ml of kanamycin. US11 was
induced by adding 1 mM isopropyl-b-thiogalatopyrano-
side (IPTG, Novagen) and incubated at 25°C. Cells were
harvested by centrifugation at 10 000 rpm for 10 min-
utes, resuspended in lysis buffer (20 mM Tris-HCL, 10
mM imidazole, 1% triton x-100, 10 mM b-mercap-
toethanol, pH 8.0) with the addition of a protease inhi-
bitor cocktail (Sigma, ON, Canada) and sonicated 5
times for 20 second intervals. Soluble and insoluble frac-
tions of protein were separated by centrifugation at
14000 rpm. Most of the US11 was found in the soluble
fractions and these fractions were stored at -20°C and
used in the experiments described in this work.
Purification of US11 Proteins
US11 proteins expressed with a His tag were purified on
a Ni affinity column, prepared by equilibrating Ni resin
(Profinity™ IMAC Ni-charged resin, Biorad, USA) with
1X binding buffer (20 mM Tris-HCL pH 7.4, 10 mM
imidazole, 1 M NaCl, 1% triton x-100, 10 mM b-mer-
captoethanol). E. coli extracts were mixed with an equal
volume of 2X binding buffer (20 mM Tris-HCL pH 7.4,
10 mM imidazole, 2 M NaCl, 1% triton x-100, 10 mM
b-mercaptoethanol) and applied to the affinity column.
The addition of 1 M NaCl in the binding buffer was
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US11 protein after lysis. The Ni column was washed
with 10 bed volumes of wash buffer 1 (20 mM Tris-
HCL, 10 mM imidazole, 1 M NaCl, 1% triton x-100, 10
mM b-mercaptoethanol pH 7.4) and then wash buffer 2
(20 mM Tris-HCL pH 7.4, 10 mM imidazole, 300 mM
NaCl, 1% triton x-100, 10 mM b-mercaptoethanol).
US11 was eluted with elution buffer (20 mM Tris-HCL
pH 7.4, 300 mM imidazole, 300 mM NaCl, 1% triton x-
100, 10 mM b-mercaptoethanol).
Ni column fractions containing US11 protein were
pooled and loaded onto a 1 ml HiTrap heparin HP col-
umn (GE Healthcare) apparatus an AKTA FPLC system
(GE Healthcare, QC, Canada), using phosphate buffer
(10 mM NaPO4 pH 7.4). The US11 protein was eluted
with a gradient of NaCl in phosphate buffer from 0 to
1.5 M, at a flow rate of 1 ml/min. Fractions containing
US11 were confirmed by SDS-PAGE on a 15% SDS-
PAGE gel and the protein concentration was measured
using the RcDc Protein Assay kit (Biorad). The identity
of US11 was confirmed by western blot analysis with an
anti-polyhistidine mouse monoclonal antibody (Sigma),
and by mass spectrometry at the Proteomics Core facil-
ity of the National Microbiology Laboratory, Winnipeg,
Manitoba.
Electrophoretic Mobility Shift Assays (EMSAs)
The RNA used for detecting protein binding was a ran-
domly designed 42 bp double stranded synthetic frag-
ment of sequence 5’UUCUCAAGUGAAGUCUGC
UGAAGUACGUAACCUUAGAUACAU3’ (Invitrogen).
A dsDNA fragment of corresponding sequence was used
as a binding control. Binding reactions were prepared
using varying concentration of purified US11 protein (4
ng - 366 ng) and 20 ng of dsRNA in binding buffer (150
mM KCl, 0.1 mM DTT, 0.1 mM EDTA and 50 mM
Tris, pH 7.4) in a final reaction volume of 20 μl. US11
a n dd s R N Aw e r ea l l o w e dt ob i n da tr o o mt e m p e r a t u r e
for 30 minutes without agitation. An aliquot of gel load-
ing buffer (0.25% bromophenol blue, 0.25% xylene cya-
nol, 15% ficoll-type 400) was added to the reaction
mixtures and resolved on 10% non-denaturing polyacry-
lamide gels in 1X TBE.
Filter Binding Assays
US11/dsRNA binding reaction was performed in 2 ml of
binding buffer (150 mM KCl, 0.1 mM DTT, 0.1 mM
EDTA and 50 mM Tris, pH 7.4) containing 5% Ni resin,
a fixed amount of purified US11 protein and variable
concentrations of
32P labeled dsRNA, obtained by seri-
ally diluting a solution of 31 nM of dsRNA trace-labeled
with about 2 × 10
6 cpm of end-labeled RNA. With this
procedure all the dilutions of dsRNA had the same spe-
cific activity. The tubes were incubated for 25 minutes
at room temperature with gentle mixing and then
loaded onto Whatman GF/C filters on a vacuum mani-
fold (VWR). The reactions were filtered immediately
and the filters were washed 3 times with 10 mL of ice
cold 1X binding buffer. The radioactivity bound to the
filter was counted using a LS 6500 scintillation counter.
Background radioactivity bound to the filter was
determined by running in parallel for each dsRNA con-
centration controls containing all the reagents except
for the US11 protein.
Determining Kd Values and Statistical Analysis
A specific activity for each experiment was calculated as
the average cpm/nmoles for each dsRNA concentration.
The pmoles of dsRNA bound to the filter for each
dsRNA concentration was calculated as:
pmoles =
cpm in sample − cpm blank
speciﬁc activity
The dissociation constant (Kd) and the total amount
of binding sites [P] was calculated by non-linear regres-
sion of the equilibrium binding equation:
[P · RNA] = [P][RNA]/(Kd + [RNA])
Where: [P·RNA] is the amount of protein and RNA
complexes as calculated from the binding experiments
and [RNA] is the concentration of dsRNA in each point.
T h es o f t w a r ea l s oe s t i m a t e dt h es t a n d a r de r r o ro ft h e
calculated Kd and [P].
Several experiments were performed to determine the
Kd of each US11 protein. A weighted average of the Kd
values and standard deviation of the weighted average
was calculated according to the formulas from Beving-
ton and Robinson [21]. A one-way ANOVA test was
performed to establish whether the Kd values were sig-
nificantly different. GraphPad Prism
® software was used
for these analyses.
Results
Protein expression and RNA binding activity
RNA-binding activity of the expressed and purified
US11 proteins was assessed by electrophoretic mobility
shift assay (EMSA). Figure 1A shows the binding activity
of US11 from HSV 1 to the 42 base pair random
sequence of RNA, as described in Materials and Meth-
ods. We chose the length of 42 base pairs based on pre-
vious work which showed that US11 from HSV1 binds a
minimum of 39 to a maximum of 300 bp of dsRNA effi-
ciently [12].
At lower concentrations of protein (lanes 4-7; 4.3 ng,
6.4 ng, 9.7 ng and 14.5 ng US11) only one shifted band
is visible by ethidium bromide staining. A second band
of higher molecular weight (MW) appears at higher
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and 49.0 ng US11) and some RNA forms a high MW
smear or remains trapped in the gel wells at the highest
protein concentration (lanes 11-12; 73.5 and 110 ng
US11). This result indicates that more than one mole-
cule of US11 protein can bind to one molecule of
dsRNA. All US11 proteins from HSV 1, HSV 2, B virus
and HVP2 remained active post-purification as they all
bound dsRNA with similar kinetics (Figure 2). US11
from SA8 did not express in the E. coli system and
therefore US11 from SA8 was not used in the rest of
the study.
US11 has been described predominantly as an RNA
binding protein, although some previous reports in the
literature show that US11 is also able to bind dsDNA
[14,15]. Figure 1B shows that US11 does bind dsDNA
but with a lower affinity and not in a discernable stoi-
chiometric manner. The dsDNA substrate used for this
experiment had a nucleotide sequence corresponding to
the sequence of the dsRNA substrate.
Determination of Kd for US11 proteins from HSV1, HSV2,
B virus and HVP2
In order to determine the Kd of US11 proteins for
dsRNA we used the filter binding assay described in
detail in Materials and Methods. For this assay the puri-
f i e dH i st a g g e dU S 1 1p r o t e i n sa r eb o u n dt oN ir e s i n
and, after incubation with 32P-labelled RNA substrate,
the free radioactivity is removed by filtration. This clas-
sic binding method has the advantage over EMSA of the
possibility of measuring the real equilibrium binding, by
using excess amounts of RNA substrate and rapidity of
washing, as opposed to the small sample volume for
electrophoresis and the many hours of an electrophor-
esis run, during which a substantial portion of RNA
bound protein may dissociate. In addition, filter binding
is more quantitative than measuring radioactivity on X-
ray image or a cut gel slice.
In order to confirm that the filter binding method was
free of artifacts that could influence the calculation of
Kd, we performed two binding kinetic experiment, using
a fixed concentration of RNA and varying concentra-
tions of Us11 (Figure 3A), or using varying concentra-
tions of RNA and a fixed concentration of Us11 protein
from HSV1 (Figure 3B). The calculated Kd were 0.65 ±
0.14 nM and 0.70 ± 0.09 nM, and they were not signifi-
cantly different as determined by an unpaired t-test (p
value = 0.7), indicating that the true Kd value was
determined.
In order to accurately measure and compare the Kd of
the US11 proteins from HSV1, HSV2, HVP2 and B
virus, we performed filter binding assays over a range of
dsRNA concentrations of 31 nM - 200 nM in parallel
for the four viruses.
Table 1 shows the results of 5 independent binding
experiments. For each experiment the Kd was calculated
by non-linear regression of the binding equation
described in Materials and Methods (as done for exam-
ple in Figure 3A) and the standard errors were also esti-
mated. The last line of table 1 reports the weighted




































































































































Figure 1 EMSA of US11 protein from HSV1, to demonstrate its ability to bind to nucleic acids. Increasing concentration of US11 protein
ranging from 4.3-112 ng (from lane 4 to 12, respectively) were incubated with 20 ng of nucleic acid substrate and then run on a 10%
acrylamide gel and stained with ethidium bromide. A) A 42 bp dsRNA was used as substrate. B) A 42 bp dsDNA with sequence corresponding
to the dsRNA was used as substrate.
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standard deviation. The standard error of the Kd calcu-
lated by the non-linear regression was used as weight.
None of the differences between Kd values for different
US11 proteins were statistically significant, as deter-
mined by a one-way ANOVA test.
There was some variation in the Kd determinations
among different experiments, but, except for experiment
3, Kds for different viruses were not significantly differ-
ent also within each experiment (Table 1, rightmost
column).
Discussion
US11 inhibits interferon-mediated shutoff of protein
synthesis by the PKR system, but its exact role during
the course of herpesvirus infection still remains unclear.
US11 is not essential for HSV replication in culture
[22], but HSV also produces a second protein that
inhibits PKR, g134.5, which is in turn essential for infec-
tivity in cells and mice. In contrast, simian simplex-
viruses lack a g134.5 gene and US11 seems to be the
only protein with PKR inhibitory activity. In order to




















































































































































































































































































































































12 3 4 56 7 8
100 100
40
Figure 2 E M S A so fU S 1 1f r o mH V P 2( A ) ,H S V2( B )a n dBv i r u s( C ) . This figure demonstrates the ability of US11 from the various viral
sources to bind to RNA. Increasing concentrations of US11 protein were incubated with 20 ng of nucleic acid substrate and run on a 10%
acrylamide gel stained with ethidium bromide. A) US11 from HVP2 is bound to RNA. Concentrations of protein include: 23 ng - 366 ng (lanes 4-
8, respectively). B) US11 from HSV2 is bound to RNA. Concentrations of protein include: 22 ng - 354 ng (lanes 4-8, respectively). C) US11 from B
virus is bound to RNA. Concentrations of protein include: 22 ng - 348 ng (lanes 4-8, respectively).
Table 1 Determination of the Kd of binding to dsRNA of
US11 proteins from four simplexviruses.
Experiment HSV1 HSV2 B virus HVP2 p
1
a 0.46 ± 0.40 0.29 ± 0.14 0.35 ± 0.28 0.42 ± 0.31 0.978
2
a 2.34 ± 0.95 0.30 ± 0.52 6.07 ± 1.40 6.28 ± 3.09 0.068
3
a 2.60 ± 1.13 1.14 ± 0.29 4.36 ± 1.35 6.10 ± 1.58 0.039
4
a 1.84 ± 0.37 1.38 ± 0.15 1.69 ± 2.35 1.13 ± 0.27 0.975
5
a 1.25 ± 0.26 1.66 ± 0.60 2.23 ± 0.94 2.58 ± 0.28 0.408
w. mean
b 1.43 ± 0.29 0.89 ± 0.42 1.82 ± 3.42 1.80 ± 3.43 0.92
a Kd calculated by non-linear regression ± estimated standard errors
b weighted average calculated using Kd standard errors as weights ±
weighted standard deviation
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dsRNA binding activity of US11 expressed from HSV-1,
HSV-2, HVP-2 and B virus.
Our results show that US11 proteins from HSV-1,
HSV-2, HVP-2 and B virus bind the dsRNA substrate
with the same affinity. In particular, there was no differ-
ence in Kd for US11 of HVP-2, despite the fact that this
protein has a higher number of dsRNA-binding repeats.
We determined the average Kd value for a synthetic
dsRNA substrate at 1.07 ± 1.86 nM. Previous studies
[12,20] have reported Kd values for US11 for different
d s R N As p e c i e sa n ds h o w e dt h a tt h ea f f i n i t yf o rd s R N A
varied and was impacted by the length of the nucleic
acid. Bryant et al. reports a Kd of 70 nM in the case of
US11 for a 67 bp dsRNA fragment which was achieved
by electrophoretic mobility-shift assays. They were also
able to map the binding site within a 46 base pair seg-
ment of the RNA. On the other hand Khoo et al.
reported an apparent Kd value of 12.6 nM for a 81 bp
dsRNA species using a filter binding assay [12]. The Kd
values obtained thus far for US11 from HSV1 may be
dependent on the size of the dsRNA fragment and prob-
ably also on the techniques used to establish the Kd
value.
Our Kd is considerably lower of the range reported in
the literature, but the method we used is more accurate
than gel retardation technique used in the previous lit-
erature. Filter binding technique allows to work at equi-
librium binding and in the presence of excess ligand.
Binding experiments under conditions of excess of
dsRNA or excess of US11 produced similar Kd values
(Figure 3), indicating that the filter binding assays truly
measures equilibrium binding.
In conclusion, there is no difference in dsRNA binding
activity among the US11 proteins of these four simplex-
viruses, also despite the higher number of repeats of the
R-X-P RNA binding motif. However, Us11 may bind
RNA as a means of homing to PKR and physically inhi-
bit the enzyme, and studies have shown that US11
forms a physical association with PKR [23]. It is also
clear that US11 inhibits PKR [11,15,16]. Therefore it is
possible that difference in expression kinetics of Us11 or
differences in the interaction of Us11 with PKR may
account for the ability of simian simplexviruses to func-
tion without expressing the g134.5 protein. Future
research should compare the effect of Us11 from differ-
ent simplexvirusees on the phosphorylation levels of
PKR or eIF2a, in vitro or in cells infected by human or
simian simplexviruses.
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